Safeguard Scientifics - SFE Stock Forecast, Price & News

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on Safeguard Scientifics in a report on Tuesday, August 9th. They issued a "hold" rating for the company.

Safeguard Scientifics Price Performance

Shares of Safeguard Scientifics stock traded up $0.07 on Friday, reaching $4.15. The company had a trading volume of 2,113 shares, compared to its average volume of 8,038. The firm's 50-day moving average price is $3.97 and its two-hundred day moving average price is $4.64. Safeguard Scientifics has a 1 year low of $3.32 and a 1 year high of $8.98.

Insider Transactions at Safeguard Scientifics

In related news, major shareholder Thomas A. Satterfield, Jr. bought 15,732 shares of the company's stock in a transaction dated Monday, May 23rd. The stock was purchased at an average price of $3.45 per share, for a total transaction of $54,275.40. Following the acquisition, the insider now owns 450,732 shares in the company, valued at $1,555,025.40. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. In other Safeguard Scientifics news, major shareholder Thomas A. Satterfield, Jr. acquired 15,732 shares of the company's stock in a transaction that occurred on Monday, May 23rd. The stock was bought at an average price of $3.45 per share, for a total transaction of $54,275.40. Following the acquisition, the insider now directly owns 450,732 shares in the company, valued at $1,555,025.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Thomas A. Satterfield, Jr. acquired 26,209 shares of the company's stock in a transaction that occurred on Tuesday, June 21st. The shares were acquired at an average price of $3.68 per share, with a total value of $96,449.12. Following the acquisition, the insider now owns 644,506 shares in the company, valued at $2,371,782.08. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 84,588 shares of company stock worth $324,827. 7.10% of the stock is currently owned by company insiders.